BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cichoż-Lach H, Michalak A. Liver injury in the era of COVID-19. World J Gastroenterol 2021; 27(5): 377-390 [PMID: 33584070 DOI: 10.3748/wjg.v27.i5.377]
URL: https://www.wjgnet.com/1007-9327/full/v27/i5/377.htm
Number Citing Articles
1
Isidora Vujčić. Outcomes of COVID-19 among patients with liver diseaseWorld Journal of Gastroenterology 2023; 29(5): 815-824 doi: 10.3748/wjg.v29.i5.815
2
Zulal Ozkurt, Esra Çınar Tanrıverdi. COVID-19: Gastrointestinal manifestations, liver injury and recommendationsWorld Journal of Clinical Cases 2022; 10(4): 1140-1163 doi: 10.12998/wjcc.v10.i4.1140
3
Dafan Chen, Min Ning, Yun Feng, Jun Liu. The early stage of COVID-19 pandemic: Gastrointestinal manifestations and liver injury in COVID-19 patients in Wuhan, ChinaFrontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.997000
4
Igor V. Maev, Mikhail A. Osadchuk. Liver disease during the pandemic of COVID-19 infection: prediction of the course and tactics of management: A reviewTerapevticheskii arkhiv 2022; 94(11): 1326 doi: 10.26442/00403660.2022.11.201934
5
Alexandre Balaphas, Kyriaki Gkoufa, Nicola Colucci, Konstantinos-Cédric Perdikis, Christophe Gaudet-Blavignac, Zoltan Pataky, Sebastian Carballo, Frédéric Ris, Jérôme Stirnemann, Christian Lovis, Nicolas Goossens, Christian Toso. Abdominal pain patterns during COVID-19: an observational studyScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-18753-0
6
Rania M. Sarhan, Hadeer S. Harb, Ahmed E. Abou Warda, Mounir M. Salem-Bekhit, Faiyaz Shakeel, Sami Ali Alzahrani, Yasmin M. Madney, Marian S. Boshra. Efficacy of the early treatment with tocilizumab-hydroxychloroquine and tocilizumab-remdesivir in severe COVID-19 PatientsJournal of Infection and Public Health 2022; 15(1): 116 doi: 10.1016/j.jiph.2021.10.024
7
S. V. Sokologorskiy, A. M. Ovechkin, I. V. Khapov, M. E. Politov, E. L. Bulanova. Risk Factors of Severe Disease and Methods for Clinical Outcome Prediction in Patients with COVID-19 (Review)General Reanimatology 2022; 18(1): 31 doi: 10.15360/1813-9779-2022-1-31-38
8
Yue Shi, Mina Wang, Liqun Wu, Xuexin Li, Zehuan Liao. COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groupsLiver Research 2023; 7(3): 207 doi: 10.1016/j.livres.2023.07.001
9
Elahe Roshanzamir, Sayed Mostafa Pourhosseni, Mohammad Bagher Sohrabi, Hamid Vahedi. Prevalence of Impaired Liver Tests in Hospitalized Patients With COVID19 and its Relationship With Length of Hospital Stay and Mortality RateSSRN Electronic Journal 2022;  doi: 10.2139/ssrn.4007458
10
Amal Oweid Almutairi, Mahmoud Zaki El-Readi, Mohammad Althubiti, Yosra Zakariyya Alhindi, Nahla Ayoub, Abdullah R. Alzahrani, Saeed S. Al-Ghamdi, Safaa Yehia Eid. Liver Injury in Favipiravir-Treated COVID-19 Patients: Retrospective Single-Center Cohort StudyTropical Medicine and Infectious Disease 2023; 8(2): 129 doi: 10.3390/tropicalmed8020129
11
Liliana Łykowska-Szuber, Karolina Wołodźko, Anna Maria Rychter, Aleksandra Szymczak-Tomczak, Iwona Krela-Kaźmierczak, Agnieszka Dobrowolska. Liver Injury in Patients with Coronavirus Disease 2019 (COVID-19)—A Narrative ReviewJournal of Clinical Medicine 2021; 10(21): 5048 doi: 10.3390/jcm10215048
12
Bircan Kayaaslan, Rahmet Guner. COVID-19 and the liver: A brief and core reviewWorld Journal of Hepatology 2021; 13(12): 2013-2023 doi: 10.4254/wjh.v13.i12.2013
13
Fouzia Shoeb, Farzana Mahdi, Imran Hussain. Gender Differences Associated with Hyper-Inflammatory Conditions in COVID-19 PatientsAging and disease 2022; : 0 doi: 10.14336/AD.2022.0830
14
Mohammad Mehdi Ommati, Ali Mobasheri, Reza Heidari. Drug‐induced organ injury in coronavirus disease 2019 pharmacotherapy: Mechanisms and challenges in differential diagnosis and potential protective strategiesJournal of Biochemical and Molecular Toxicology 2021; 35(7) doi: 10.1002/jbt.22795
15
Reza Afrisham, Yasaman Jadidi, Maryam Davoudi, Kiana Moayedi, Omid Soliemanifar, Chrysovalantou Eleni Xirouchaki, Damoon Ashtary-Larky, Shadisadat Seyyedebrahimi, Shaban Alizadeh. Gastrointestinal, Liver, Pancreas, Oral and Psychological Long-term Symptoms of COVID-19 After Recovery: A ReviewMini-Reviews in Medicinal Chemistry 2023; 23(7): 852 doi: 10.2174/1389557523666221116154907
16
Lekha Saha, Soumya Vij, Kajal Rawat. Liver injury induced by COVID 19 treatment – what do we know?World Journal of Gastroenterology 2022; 28(45): 6314-6327 doi: 10.3748/wjg.v28.i45.6314
17
Diana I. Abdulganieva, Dilyara D. Mukhametova, Nailya G. Shamsutdinova, Alsou M. Galieva. Abnormal liver function tests in patients with COVID-19Experimental and Clinical Gastroenterology 2022; (7): 123 doi: 10.31146/1682-8658-ecg-203-7-123-130
18
George D Liatsos. SARS-CoV-2 induced liver injury: Incidence, risk factors, impact on COVID-19 severity and prognosis in different population groupsWorld Journal of Gastroenterology 2023; 29(16): 2397-2432 doi: 10.3748/wjg.v29.i16.2397
19
Sarah El-Nakeep. Frontiers of COVID-192022; : 291 doi: 10.1007/978-3-031-08045-6_14
20
Wiwat Chancharoenthana, Supitcha Kamolratanakul, Asada Leelahavanichkul, Wassawon Ariyanon, Sutatip Chinpraditsuk, Rattanaporn Saelim, Somratai Vadcharavivad, Weerapong Phumratanaprapin, Polrat Wilairatana. Gastrointestinal manifestations of long-term effects after COVID-19 infection in patients with dialysis or kidney transplantation: An observational cohort studyWorld Journal of Gastroenterology 2023; 29(19): 3013-3026 doi: 10.3748/wjg.v29.i19.3013
21
Yuyin Fang, Peizhen Lao, Longqian Tang, Jingyi Chen, Yuxi Chen, Lei Sun, Wenwen Tan, Xingliang Fan. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 TreatmentCell Transplantation 2023; 32 doi: 10.1177/09636897231184611
22
Eleni Karlafti, Daniel Paramythiotis, Konstantina Pantazi, Vasiliki Epameinondas Georgakopoulou, Georgia Kaiafa, Petros Papalexis, Adonis A. Protopapas, Eleftheria Ztriva, Varvara Fyntanidou, Christos Savopoulos. Drug-Induced Liver Injury in Hospitalized Patients during SARS-CoV-2 InfectionMedicina 2022; 58(12): 1848 doi: 10.3390/medicina58121848
23
Carmine Finelli. Gut Microbiota, NAFLD and COVID-19: A Possible InteractionObesities 2022; 2(2): 215 doi: 10.3390/obesities2020017
24
Marcos Roberto Tovani-Palone, Paolo Pedersini. Potential role of the microbiome in liver injury during COVID-19: Further research is neededWorld Journal of Gastroenterology 2023; 29(3): 503-507 doi: 10.3748/wjg.v29.i3.503
25
I. N. Tikhonov, V. T. Ivashkin, M. S. Zharkova, M. V. Maevskaya, S. N. Koloteeva, A. S. Sarsenbaeva, L I. Tkachenko, O. V. Aronova, E. K. Tsvetaeva, N I. Trofimovskaya. Results of the non-interventional observational program: Influence of Novel COroNavirus on the condition of patients with liver and gastrointestinal Tract diseases and the effect of Ursodeoxycholic acid drugs and Rebamipide on the course of COVID-19 infection (CONTUR)Meditsinskiy sovet = Medical Council 2022; (21-1): 106 doi: 10.21518/2079-701X-2021-21-1-106-119
26
Tian LAN, Xiaolin LIANG, Xiaoyu HU, Wuping WANG, Laiyou WANG, Ling YANG, Lexun WANG, Xianglu RONG, Jiao GUO. A neglected complication of COVID-19: liver injuryJournal of Holistic Integrative Pharmacy 2021; 2(1): 11 doi: 10.1016/S2707-3688(23)00019-5
27
Nazanin Aghamohamadi, Faezeh Shahba, Ali Zarezadeh Mehrabadi, Hossein Khorramdelazad, Milad Karimi, Reza Falak, Reza Zolfaghari Emameh. Age-dependent immune responses in COVID-19-mediated liver injury: focus on cytokinesFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1139692
28
Titus Rössler, Georgy Berezhnoy, Yogesh Singh, Claire Cannet, Tony Reinsperger, Hartmut Schäfer, Manfred Spraul, Manfred Kneilling, Uta Merle, Christoph Trautwein. Quantitative Serum NMR Spectroscopy Stratifies COVID-19 Patients and Sheds Light on Interfaces of Host Metabolism and the Immune Response with Cytokines and Clinical ParametersMetabolites 2022; 12(12): 1277 doi: 10.3390/metabo12121277
29
Khansa Ahsan, Munir Ahmad Anwar, Nayla Munawar. Gut microbiome therapeutic modulation to alleviate drug-induced hepatic damage in COVID-19 patientsWorld Journal of Gastroenterology 2023; 29(11): 1708-1720 doi: 10.3748/wjg.v29.i11.1708
30
Ming-Ke Wang, Xue-Lu Yu, Li-Yun Zhou, Hong-Mei Si, Ju-Fen Hui, Deng-Yong Hou, Wei-Peng Li, Ji-Shun Yang. COVID-19 and liver dysfunction: What nutritionists need to knowWorld Journal of Gastroenterology 2022; 28(15): 1526-1535 doi: 10.3748/wjg.v28.i15.1526
31
Effie Polyzogopoulou, Pinelopi Amoiridou, Theodore P Abraham, Ioannis Ventoulis. Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative reviewWorld Journal of Gastroenterology 2022; 28(47): 6662-6688 doi: 10.3748/wjg.v28.i47.6662
32
Mariana Helou, Janane Nasr, Nour El Osta, Elsy Jabbour, Rola Husni. Liver manifestations in COVID-19 patients: A review articleWorld Journal of Clinical Cases 2023; 11(10): 2189-2200 doi: 10.12998/wjcc.v11.i10.2189
33
Gianni TESTINO, Rinaldo PELLICANO. Acute-on-chronic liver failure by SARS-CoV-2 in active alcohol use disorder cirrhotic patientMinerva Gastroenterology 2021; 67(3) doi: 10.23736/S2724-5985.21.02893-X
34
Mihaela Cătălina Luca, Isabela Ioana Loghin, Ioana Florina Mihai, Radu Popa, Andrei Vâţă, Carmen Manciuc. Liver Damage Associated with SARS-CoV-2 Infection—Myth or Reality?Journal of Personalized Medicine 2023; 13(2): 349 doi: 10.3390/jpm13020349
35
Andrei Voiosu, Adina Roman, Ruxandra Pop, Alina Boeriu, Cristiana Popp, Sabina Zurac, Theodor Voiosu, Daniela Dobru, Bogdan Mateescu. Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experienceRomanian Journal of Internal Medicine 2022; 60(1): 49 doi: 10.2478/rjim-2021-0027
36
Abhishek Singhai, GSai Pavan, Smritimayee Panda. Evaluation of liver function in symptomatic COVID-19 patientsJournal of Family Medicine and Primary Care 2021; 10(9): 3252 doi: 10.4103/jfmpc.jfmpc_2527_20
37
Neira Crnčević, Zijah Rifatbegović, Mirsada Hukić, Sara Deumić, Emina Pramenković, Amir Selimagić, Ismet Gavrankapetanović, Monia Avdić. Atypical Viral Infections in GastroenterologyDiseases 2022; 10(4): 87 doi: 10.3390/diseases10040087
38
必琼 张. Research Progress of COVID-19 Vaccination in Patients with Chronic Liver DiseasesAdvances in Clinical Medicine 2023; 13(06): 9060 doi: 10.12677/ACM.2023.1361268
39
Ioannis G Lempesis, Eleni Karlafti, Petros Papalexis, George Fotakopoulos, Kyriakos Tarantinos, Vasileios Lekakis, Stavros P Papadakos, Evangelos Cholongitas, Vasiliki E Georgakopoulou. COVID-19 and liver injury in individuals with obesityWorld Journal of Gastroenterology 2023; 29(6): 908-916 doi: 10.3748/wjg.v29.i6.908
40
Bianca Cerbu, Stelian Pantea, Felix Bratosin, Iulia Vidican, Mirela Turaiche, Stefan Frent, Ema Borsi, Iosif Marincu. Liver Impairment and Hematological Changes in Patients with Chronic Hepatitis C and COVID-19: A Retrospective Study after One Year of PandemicMedicina 2021; 57(6): 597 doi: 10.3390/medicina57060597
41
Anisha Choudhary, Vinita Singh, Murari Bharadwaj, Archana Barik. Pregnancy With SARS-CoV-2 Infection Complicated by Preeclampsia and Acute Fatty Liver of PregnancyCureus 2021;  doi: 10.7759/cureus.15645
42
Deepak Parchwani, Amit D Sonagra, Sagar Dholariya, Anita Motiani, Ragini Singh. COVID-19-related liver injury: Focus on genetic and drug-induced perspectivesWorld Journal of Virology 2023; 12(1): 53-67 doi: 10.5501/wjv.v12.i1.53
43
L.D. Sadretdinova, Kh.Kh. Gantseva, D.S. Vishnyakov, V.B. Golubyatnikov, D.Kh. Kalimullina, V.N. Pavlov, A.V. Tyurin. Gastrointestinal injury in COVID-19Profilakticheskaya meditsina 2022; 25(7): 106 doi: 10.17116/profmed202225071106
44
Zeinab Nabil Ahmed Said, Safinaz Adel El Habashy, Samy Zaky, ESCMID Study Group for Viral Hepatitis. COVID-19-induced transaminitis and hyperbilirubinemia: Presentation and outcomesWorld Journal of Gastroenterology 2023; 29(7): 1123-1130 doi: 10.3748/wjg.v29.i7.1123